Baakliny M, Ghosn N, Saleh N, Maison P, et al. Effectiveness of the Pfizer-BioNTech (BNT162b2) vaccine against the omicron variant of SARS-CoV-2 among adults aged 50 and above: A case-control study in Lebanon, June 2022. PLoS One 2025;20:e0318344.
PMID: 40112019